Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes. - Wikidata - wikimedia - TriplyDB

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

http://www.wikidata.org/entity/Q35545322

about

Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies.Genome-wide association analysis reveals genetic loci and candidate genes for feeding behavior and eating efficiency in Duroc boars.Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.Correction: Variable expression of PIK3R3 and PTEN in Ewing sarcoma impacts oncogenic phenotypes.The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth

P2860

Q28550980-FD5906C2-E431-47AD-A18E-73A7F32A5FC9 Q36380991-C6029DB7-468C-47F9-921E-466C4B9CF833 Q38379348-4A05B144-A4B3-47E5-BA3F-1B599CD7C4BE Q38429787-FDF37D57-623D-4AAA-9640-194B390638B0 Q42131196-4EB35BA2-2127-4615-A18D-6AE568DCA8FA Q43196868-45E40102-066B-4F33-9319-D7B8996C043E Q58764432-35996BC3-E690-4184-85D4-C4674BCA435A

P2860

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

http://www.wikidata.org/entity/Q35545322

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

@ast

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

@en

type

label

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

@ast

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

@en

prefLabel

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

@ast

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

@en

P1433

Q35545322-D217C321-358C-4E64-9F6D-1763374A484B

P1476

Q35545322-796A7106-45DA-41B0-BB0F-BBBE485E5DE1

P2093

Q35545322-79667E27-43C6-4A72-99E6-93DD508EC73C

Q35545322-906EB667-4B03-4183-8BC2-81C3A40543F9

Q35545322-96700DE7-B114-496B-A87B-BBAC155A83B9

Q35545322-A9B9F63A-A0BA-4D56-A8BC-9795021C048B

Q35545322-DB9E9964-F34B-446A-B03D-19C76E99C04A

P2860

Q35545322-02B84D91-7019-4B30-9B34-BABB174739BA

Q35545322-0B6D559F-FDEB-4BCE-BDAD-566B06954EE1

Q35545322-13287BE4-4307-4804-863D-C1BE160ABFE9

Q35545322-17B41D9A-2F22-41C3-8810-11107B775D48

Q35545322-1B0B41C4-2529-40AB-8DC0-250D82A6D5D9

Q35545322-1F3B7A56-EC87-447D-A7F5-3E26AA6C5369

Q35545322-22DD5050-A43A-440F-BF61-811D8FE4C6D1

Q35545322-28D55009-17BE-4217-A913-09735CA2C678

Q35545322-32AB5FF8-02D9-408A-A975-207BC1B7D1A4

Q35545322-3544378E-BFAE-427F-93BC-5D150C7CED0C

P304

Q35545322-D804F961-7A1A-4712-BB8B-562AA117782E

P31

Q35545322-2DB45AB0-0EBF-48A3-B802-58C9A148AE80

P356

Q35545322-1CDA24D3-1673-4AE3-AF98-EA82D19E8762

P407

Q35545322-931BEE9F-FB97-4174-9F73-B49EA37B8067

P433

Q35545322-39BF071C-8BAD-44F1-A3DB-4C24F9D04B50

P478

Q35545322-8E6D2CC1-530A-4496-8DC5-43AB0AC73FE0

P50

Q35545322-11BE4F75-304B-41AD-82E0-FD8E10715FDE

P577

Q35545322-CD489908-02B6-4470-B481-F58345868BEE

P5875

Q35545322-09E14189-452E-4845-894B-2323C0156B00

P698

Q35545322-770F5164-FA37-4993-9D44-32CC7596B350

P932

Q35545322-6132B7AA-C937-4046-A60C-6D67B6C4891B

P356

JOURNAL.PONE.0116895

P1433

P1476

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

@en

P2093

Janet K Parrish

http://www.w3.org/2001/XMLSchema#string

Jennifer K Richer

http://www.w3.org/2001/XMLSchema#string

Nicole S Spoelstra

http://www.w3.org/2001/XMLSchema#string

Paul Jedlicka

http://www.w3.org/2001/XMLSchema#string

Teresa Joyal

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner

The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma

Pten dose dictates cancer progression in the prostate

Essential role for nuclear PTEN in maintaining chromosomal integrity

Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.

Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway.

Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia

PTEN interacts with histone H1 and controls chromatin condensation.

P304

e0116895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0116895

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Brian F Niemeyer

P577

2015-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271534275

http://www.w3.org/2001/XMLSchema#string

P698

25603314

http://www.w3.org/2001/XMLSchema#string

P932

4300218

http://www.w3.org/2001/XMLSchema#string